{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:27:32Z","timestamp":1791206852941,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1124\/jpet.114.218560","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T04:25:35Z","timestamp":1423023935000},"page":"132-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3\u2013Related Dwarfism"],"prefix":"10.1016","volume":"353","author":[{"given":"Daniel J.","family":"Wendt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita","family":"Dvorak-Ewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Bullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lorget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sianna","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Aoyagi-Scharber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Krejci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Rimoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Bunting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.218560_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/en.2002-220702","article-title":"Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B","volume":"144","author":"Abbey","year":"2003","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.114.218560_bib2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0196-9781(96)00110-6","article-title":"C-type natriuretic peptide","volume":"17","author":"Barr","year":"1996","journal-title":"Peptides"},{"key":"10.1124\/jpet.114.218560_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/422013","article-title":"Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux","volume":"75","author":"Bartels","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1124\/jpet.114.218560_bib4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/humu.20511","article-title":"Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation","volume":"28","author":"Bocciardi","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1124\/jpet.114.218560_bib5","first-page":"H326","article-title":"Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide","volume":"269","author":"Brandt","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.114.218560_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/01.HYP.30.2.184","article-title":"Neutral endopeptidase regulates C-type natriuretic peptide metabolism but does not potentiate its bioactivity in vivo","volume":"30","author":"Brandt","year":"1997","journal-title":"Hypertension"},{"key":"10.1124\/jpet.114.218560_bib7","first-page":"R201","article-title":"Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep","volume":"268","author":"Charles","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.114.218560_bib8","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.218560_bib9","first-page":"R290","article-title":"C-type natriuretic peptide: a selective cardiovascular peptide","volume":"264","author":"Clavell","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.114.218560_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.2042-7158.1955.tb12043.x","article-title":"The operating characteristics of some official weight variation tests for tablets","volume":"7","author":"Dunnett","year":"1955","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/jpet.114.218560_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1096\/fasebj.3.2.2521610","article-title":"Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones","volume":"3","author":"Erd\u00f6s","year":"1989","journal-title":"FASEB J"},{"key":"10.1124\/jpet.114.218560_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00041433-200208000-00009","article-title":"The myotoxicity of statins","volume":"13","author":"Evans","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/jpet.114.218560_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.21636","article-title":"Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias","volume":"33","author":"Foldynova-Trantirkova","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1124\/jpet.114.218560_bib14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0006-291X(05)80284-0","article-title":"Structural requirements of C-type natriuretic peptide for elevation of cyclic GMP in cultured vascular smooth muscle cells","volume":"183","author":"Furuya","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.114.218560_bib15","doi-asserted-by":"crossref","first-page":"203ra124","DOI":"10.1126\/scitranslmed.3006247","article-title":"Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice","volume":"5","author":"Garcia","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1124\/jpet.114.218560_bib16","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1074\/jbc.M110.205583","article-title":"FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism","volume":"286","author":"He","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.218560_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/088307389000500203","article-title":"Neurologic morbidity associated with achondroplasia","volume":"5","author":"Hecht","year":"1990","journal-title":"J Child Neurol"},{"key":"10.1124\/jpet.114.218560_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/jpet.114.218560_bib19","first-page":"1428","article-title":"Bioactivity and metabolism of C-type natriuretic peptide in normal man","volume":"78","author":"Hunt","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.114.218560_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1291\/hypres.21.7","article-title":"Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide","volume":"21","author":"Igaki","year":"1998","journal-title":"Hypertens Res"},{"key":"10.1124\/jpet.114.218560_bib21","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/hmg\/9.11.1603","article-title":"A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos","volume":"9","author":"Iwata","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.114.218560_bib22","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1093\/hmg\/dds390","article-title":"A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia","volume":"21","author":"Jin","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.114.218560_bib23","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.1152\/ajpendo.00272.2009","article-title":"Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice","volume":"297","author":"Kake","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.114.218560_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/bj1370477","article-title":"The purification and specificity of a neutral endopeptidase from rabbit kidney brush border","volume":"137","author":"Kerr","year":"1974","journal-title":"Biochem J"},{"key":"10.1124\/jpet.114.218560_bib25","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1242\/jcs.02618","article-title":"Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis","volume":"118","author":"Krejci","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1124\/jpet.114.218560_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1593\/neo.04214","article-title":"Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing","volume":"6","author":"Kurtz","year":"2004","journal-title":"Neoplasia"},{"key":"10.1124\/jpet.114.218560_bib27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOP.0b013e32833b7a69","article-title":"Achondroplasia: pathogenesis and implications for future treatment","volume":"22","author":"Laederich","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1124\/jpet.114.218560_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jbiotec.2012.08.001","article-title":"A novel method for the large-scale production of PG-CNP37, a C-type natriuretic peptide analogue","volume":"164","author":"Long","year":"2012","journal-title":"J Biotechnol"},{"key":"10.1124\/jpet.114.218560_bib29","doi-asserted-by":"crossref","first-page":"23064","DOI":"10.1074\/jbc.272.37.23064","article-title":"The guanylyl cyclase-deficient mouse defines differential pathways of natriuretic peptide signaling","volume":"272","author":"Lopez","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.218560_bib30","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","article-title":"Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia","volume":"91","author":"Lorget","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1124\/jpet.114.218560_bib31","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1172\/JCI114210","article-title":"Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds","volume":"84","author":"Lynch","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.218560_bib32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4103\/2230-8210.113754","article-title":"Safety of statins","volume":"17","author":"Maji","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1124\/jpet.114.218560_bib33","doi-asserted-by":"crossref","first-page":"e81569","DOI":"10.1371\/journal.pone.0081569","article-title":"Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia","volume":"8","author":"Matsushita","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.114.218560_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/hmg\/ddn339","article-title":"FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway","volume":"18","author":"Matsushita","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.114.218560_bib35","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11999-008-0142-6","article-title":"Lumbar nerve root occupancy in the foramen in achondroplasia: a morphometric analysis","volume":"466","author":"Modi","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"10.1124\/jpet.114.218560_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/humu.20611","article-title":"A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype","volume":"28","author":"Moncla","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1124\/jpet.114.218560_bib37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.114.218560_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1469-1809.1970.tb01648.x","article-title":"Achondroplasia\u2014a genetic and statistical survey","volume":"33","author":"Murdoch","year":"1970","journal-title":"Ann Hum Genet"},{"key":"10.1124\/jpet.114.218560_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20111876","article-title":"Epithelial-mesenchymal interaction during UVB-induced up-regulation of neutral endopeptidase","volume":"443","author":"Nakajima","year":"2012","journal-title":"Biochem J"},{"key":"10.1124\/jpet.114.218560_bib40","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"key":"10.1124\/jpet.114.218560_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/jmbi.1999.3492","article-title":"Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon","volume":"296","author":"Oefner","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1124\/jpet.114.218560_bib42","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","article-title":"FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease","volume":"16","author":"Ornitz","year":"2002","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.114.218560_bib43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00109-007-0183-4","article-title":"Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy","volume":"85","author":"Pagel-Langenickel","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"10.1124\/jpet.114.218560_bib44","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/ar4253","article-title":"Natriuretic peptide receptors regulate cytoprotective effects in a human ex vivo 3D\/bioreactor model","volume":"15","author":"Peake","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/jpet.114.218560_bib45","doi-asserted-by":"crossref","first-page":"e46678","DOI":"10.1371\/journal.pone.0046678","article-title":"Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET","volume":"7","author":"Placone","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.114.218560_bib46","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1742-4658.2011.08082.x","article-title":"Natriuretic peptide metabolism, clearance and degradation","volume":"278","author":"Potter","year":"2011","journal-title":"FEBS J"},{"key":"10.1124\/jpet.114.218560_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Potter","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.114.218560_bib48","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1074\/jbc.R000033200","article-title":"Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation","volume":"276","author":"Potter","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.218560_bib49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJM197010012831404","article-title":"Endochondral ossification in achondroplastic dwarfism","volume":"283","author":"Rimoin","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.218560_bib50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"10.1124\/jpet.114.218560_bib51","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1359\/jbmr.2000.15.7.1266","article-title":"Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides","volume":"15","author":"Ruchon","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1124\/jpet.114.218560_bib52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.5.4.371","article-title":"Advances in PEGylation of important biotech molecules: delivery aspects","volume":"5","author":"Ryan","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1124\/jpet.114.218560_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pharmthera.2004.08.011","article-title":"C-type natriuretic peptide in vascular physiology and disease","volume":"105","author":"Scotland","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.114.218560_bib54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jor.21262","article-title":"Genetic inactivation of ERK1 and ERK2 in chondrocytes promotes bone growth and enlarges the spinal canal","volume":"29","author":"Sebastian","year":"2011","journal-title":"J Orthop Res"},{"key":"10.1124\/jpet.114.218560_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005344-199609000-00008","article-title":"Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors","volume":"28","author":"Seymour","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.114.218560_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5435\/00124635-200904000-00004","article-title":"Achondroplasia: manifestations and treatment","volume":"17","author":"Shirley","year":"2009","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1124\/jpet.114.218560_bib57","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/508433","article-title":"A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome","volume":"79","author":"Toydemir","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1124\/jpet.114.218560_bib58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1542\/peds.2005-1440","article-title":"Health supervision for children with achondroplasia","volume":"116","author":"Trotter","year":"2005","journal-title":"Pediatrics"},{"key":"10.1124\/jpet.114.218560_bib59","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.114.218560_bib60","doi-asserted-by":"crossref","first-page":"14150","DOI":"10.1016\/S0021-9258(18)77280-3","article-title":"The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase)","volume":"265","author":"Vijayaraghavan","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.218560_bib61","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/tea.2007.0035","article-title":"Differential effects of natriuretic peptide stimulation on tissue-engineered cartilage","volume":"14","author":"Waldman","year":"2008","journal-title":"Tissue Eng Part A"},{"key":"10.1124\/jpet.114.218560_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/bmme.1997.2584","article-title":"Comparison of the hydrolysis of the three types of natriuretic peptides by human kidney neutral endopeptidase 24.11","volume":"61","author":"Watanabe","year":"1997","journal-title":"Biochem Mol Med"},{"key":"10.1124\/jpet.114.218560_bib63","doi-asserted-by":"crossref","first-page":"17664","DOI":"10.1074\/jbc.M212723200","article-title":"Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells","volume":"278","author":"Wielinga","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.218560_bib64","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/ajmg.a.31919","article-title":"Mortality in achondroplasia study: a 42-year follow-up","volume":"143A","author":"Wynn","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1124\/jpet.114.218560_bib65","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"Yamashita","year":"2014","journal-title":"Nature"},{"key":"10.1124\/jpet.114.218560_bib66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/oxfordjournals.jbchem.a022591","article-title":"Concentration of mRNA for the natriuretic peptide receptor-C in hypertrophic chondrocytes of the fetal mouse tibia","volume":"127","author":"Yamashita","year":"2000","journal-title":"J Biochem"},{"key":"10.1124\/jpet.114.218560_bib67","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/en.2008-1676","article-title":"Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias","volume":"150","author":"Yasoda","year":"2009","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.114.218560_bib68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat Med"},{"key":"10.1124\/jpet.114.218560_bib69","doi-asserted-by":"crossref","first-page":"11695","DOI":"10.1074\/jbc.273.19.11695","article-title":"Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide\/guanylyl cyclase-B pathway","volume":"273","author":"Yasoda","year":"1998","journal-title":"J Biol Chem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.218560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:58:39Z","timestamp":1739987919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524189872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0022356524189872"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.218560","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3\u2013Related Dwarfism","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.218560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}